Biotech’s financing flurry & Distillery spotlight: BioCentury’s latest podcast

Plus: the latest on anti-China bills in Congress, the Inflation Reduction Act

The $3 billion raised by biotechs in a series of follow-ons and PIPEs last week marked another strong showing for a sector seeking to outrun the bear market. On the latest BioCentury This Week podcast, BioCentury’s Stephen Hansen assesses the state of fundraising for biotechs and their performance in the after-market.

BioCentury Director of Biopharma Intelligence Karen Tkach Tuzman previewed a forthcoming analysis of preclinical papers published in the Distillery, BioCentury’s coverage of translational science, and Washington Editor Steve Usdin describes the latest on anti-China bills in Congress and Inflation Reduction Act litigation. Plus Stephen Hansen discusses Closed Loop Medicine Ltd.’s program that seeks to bring precision medicine to obesity — without limiting market size.

For information on opportunities to sponsor The BioCentury Show and the BioCentury This Week podcast, please contact BioCentury at conferences@biocentury.com.